Doxorubicin-Bound Hydroxyethyl Starch Conjugate Nanoparticles with pH/Redox Responsive Linkage for Enhancing Antitumor Therapy
Open Access
- 1 July 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in International Journal of Nanomedicine
- Vol. ume 16, 4527-4544
- https://doi.org/10.2147/ijn.s314705
Abstract
Background: Chemotherapeutic drugs used for tumor treatments often show limited efficiency due to their short lifetime, nonspecific delivery, and slow or insufficient intracellular drug release, and also, they can cause severe system or organ toxicity. The development of chemotherapeutic nanomedicines with high efficacy and satisfactory safety still remains a challenge for current tumor chemotherapy. Methods: A novel type of conjugate was synthesized using hydroxyethyl starch (HES) as a carrier while binding doxorubicin (DOX) onto HES backbone through a pH/redox responsive linker containing both disulfide and hydrazone bonds in series. The built conjugates were self-assembled into nanoparticles (NPs) (HES-SS-hyd-DOX NPs) for achieving enhanced antitumor therapy and adequate safety. Results: HES-SS-hyd-DOX NPs had a certain ability for the tumor-orientated drug accumulation and were capable of releasing DOX itself rather than DOX derivatives. It was found that the pH/redox responsive linkage enabled the NPs to achieve fast and sufficient intracellular drug release. Based on the tumor-bearing mouse model, antitumor results demonstrated that these NPs were able to inhibit the growth of the advanced tumors with significantly enhanced efficacy when compared to free DOX, and to those conjugate NPs containing only a single responsive or unresponsive bond. Besides, HES-SS-hyd-DOX NPs also showed adequate safety to the normal organs of the treated mice. Conclusion: The pH/redox responsive linkage in HES-SS-hyd-DOX was found to play a critical role in mediating the drug accumulation and the fast and sufficient intracellular drug release. The HES-exposed surface of HES-SS-hyd-DOX NPs endowed the NPs with long circulation capability and remarkably reduced the DOX-induced side effects.Keywords
This publication has 55 references indexed in Scilit:
- Water-Soluble Conjugated Polymers for Imaging, Diagnosis, and TherapyChemical Reviews, 2012
- Nanoparticle Delivery of Cancer DrugsAnnual Review of Medicine, 2012
- Tailor-Made Dual pH-Sensitive Polymer–Doxorubicin Nanoparticles for Efficient Anticancer Drug DeliveryJournal of the American Chemical Society, 2011
- Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene deliveryJournal of Controlled Release, 2011
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdvanced Drug Delivery Reviews, 2011
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Drug Resistance and the Solid Tumor MicroenvironmentJNCI Journal of the National Cancer Institute, 2007
- Effects of two different hydroxyethyl starch solutions (HES200/0.5 vs. HES130/0.4) on the expression of platelet membrane glycoproteinActa Anaesthesiologica Scandinavica, 2006
- Drug penetration in solid tumoursNature Reviews Cancer, 2006
- Repopulation of cancer cells during therapy: an important cause of treatment failureNature Reviews Cancer, 2005